More About Daisy
Daisy Wolf is an investing partner at Andreessen Horowitz, where she focuses on healthcare technology. In particular, she specializes in healthcare AI and software, consumer health, and the intersection of healthcare and fintech. Daisy is involved with companies like Honor, Marker Learning, Pomelo Care, Ribbon Health, and Season Health.
Prior to joining Andreessen Horowitz, Daisy worked at Meta in the Global Business Group, where she led company growth efforts within government and politics. In addition, Daisy has held various roles at multiple startups and covered technology at a hedge fund.
Daisy holds a JD from Yale Law School, an MBA from the Stanford Graduate School of Business, and a BA, Phi Beta Kappa from Yale College. Daisy is based in New York City and her interests include musical theater, political memoirs, and poker.
Featured Content
-
While the Google --> WebMD --> Friend protocol may be a common way to enter into the healthcare system, it is certainly not an optimal one. Most of us are not well-equipped to self-diagnose from a list of possible conditions, and our friends who work in healthcare often don’t have the exact expertise we need.
-
Building specialist AIs to perform healthcare tasks offers the most challenging technical problems in the field today, as well as the greatest opportunity for impact.
-
We believe that any new technology has to be 10 times better to successfully displace the last one – marginal improvements aren’t worth the effort. Enterprise software struggled to clear that 10x bar in healthcare; AI clears it easily.
-
The most impactful companies are built at the frontier, and healthcare is the next frontier. It’s time to put our tech skills to work. The mother of all markets is ripe for disruption.
-
At a16z, marketplaces represent one of our favorite business models. Our annual Marketplace 100 provides insight into the latest consumer marketplace trends across industries.